hexamethonium has been researched along with Sleep Apnea, Obstructive in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Sleep Apnea, Obstructive: A disorder characterized by recurrent apneas during sleep despite persistent respiratory efforts. It is due to upper airway obstruction. The respiratory pauses may induce HYPERCAPNIA or HYPOXIA. Cardiac arrhythmias and elevation of systemic and pulmonary arterial pressures may occur. Frequent partial arousals occur throughout sleep, resulting in relative SLEEP DEPRIVATION and daytime tiredness. Associated conditions include OBESITY; ACROMEGALY; MYXEDEMA; micrognathia; MYOTONIC DYSTROPHY; adenotonsilar dystrophy; and NEUROMUSCULAR DISEASES. (From Adams et al., Principles of Neurology, 6th ed, p395)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schneider, H | 1 |
| Schaub, CD | 1 |
| Chen, CA | 1 |
| Andreoni, KA | 1 |
| Schwartz, AR | 1 |
| Smith, PL | 1 |
| Robotham, JL | 1 |
| O'Donnell, CP | 1 |
1 other study available for hexamethonium and Sleep Apnea, Obstructive
| Article | Year |
|---|---|
Neural and local effects of hypoxia on cardiovascular responses to obstructive apnea.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Disease Models, Animal; Do | 2000 |